▶ 調査レポート

ニチノール医療機器の世界市場2020-2025

• 英文タイトル:Nitinol Medical Devices Market - Growth, Trends, and Forecast (2020 - 2025)

Mordor Intelligenceが調査・発行した産業分析レポートです。ニチノール医療機器の世界市場2020-2025 / Nitinol Medical Devices Market - Growth, Trends, and Forecast (2020 - 2025) / D0MOR-NV008資料のイメージです。• レポートコード:D0MOR-NV008
• 出版社/出版日:Mordor Intelligence / 2020年10月30日
• レポート形態:英文、PDF、112ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥565,250 (USD4,250)▷ お問い合わせ
  Team User¥631,750 (USD4,750)▷ お問い合わせ
  Corporate License¥798,000 (USD6,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、ニチノール医療機器の世界市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別(ステント、バスケット、ガイドワイヤー、その他)分析、用途別(心臓血管、泌尿器科、歯科、その他)分析、地域別分析、競争状況、市場機会・将来動向などを整理しました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・技術ナップショット
・ニチノール医療機器の世界市場規模:製品別(ステント、バスケット、ガイドワイヤー、その他)
・ニチノール医療機器の世界市場規模:用途別(心臓血管、泌尿器科、歯科、その他)
・ニチノール医療機器の世界市場規模:地域別
・競争状況
・市場機会・将来動向

The Nitinol Medical Devices Market is expected to register a CAGR of 9.1% over the forecast period. Growing burden of diseases and increasing adoption of minimally invasive surgeries is expected to propel the global nitinol medical devices market growth. Nitinol known for its super-elasticity, has wide number of applications in the healthcare industry. According to the World Health Organization, cardiovascular disease is the major cause of death worldwide and around 17.9 million people die due to it. With the higher burden of diseases such as cardiovascular disorders, renal lithiasis, etc., the demand for nitinol medical devices is also expected to increase. However, the presence of alternative to these devices may impel the nitinol medical devices market growth.

[Key Market Trends]
Stents Segment is Expected to Hold a Major Share in the Nitinol medical Devices Market

• Stents are tiny tubes that are used for insertion into a blocked passageway. Nitinol stents exhibit some unique properties that makes it more efficient than other stents. These stents are engineered in such a way that when inserted, it adjusts itself into the wall of the vessel and resists it’s forces. Also, these stents are less corrosive even though there is a presence of nickel.

• According to the American Cancer Society, approximately 18,440 new cases have been diagnosed with esophageal cancer for the year 2020, in the United States. Such factors helps the care providers to use better stents in the market where the nitinol stents are useful and commonly due to its self-expanding characteristic, thereby, expected to drive the stents segment.

• Furthermore, adoption of minimally invasive surgeries is expected to influence positively on the nitinol stents segment. For instance, angioplasty is a minimal invasive surgery that requires a balloon tipped catheter to insert into a blocked vessel and a stent to inflate the balloon. According to the study of Eurostat, in 2017, around 1.2 million procedures related to transluminal coronary angioplasty were conducted.

[North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period]
North America is expected to be a dominant region in nitinol medical devices market growth due to the growing burden of diseases and increase in adoption of minimally invasive procedures. Coronary heart disease also known as ischemic heart disease is caused due to formation of plaque in the wall of arteries. According to the Centre for Disease Control and Prevention, coronary artery disease is one of the most affected heart diseases in the United States. In coronary artery disease, plaque builds up and blocks the arteries as a result there is improper flow of blood. For removal of these blockages generally stents are used. Hence, these factor is expected to impact positively on the nitinol medical devices market growth in this particular region.

[Competitive Landscape]
The Nitinol medical Devices Market is fragmented and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are EndoSmart GmbH, Boston Scientific Inc., B. Braun Melsungen, Arthrex Inc., Zimmer Biomet, Cook Medical, Terumo IS, Merck KGaA, Becton, Dickinson & Company and W.L. Gore & Associate Inc.

[Reasons to Purchase this report]
• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

レポート目次

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Chronic Diseases
4.2.2 Rising Preference for Minimally Invasive Surgeries
4.3 Market Restraints
4.3.1 High-cost of Devices
4.3.2 Presence of Alternative Devices
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Stents
5.1.2 Baskets
5.1.3 Guidewires
5.1.4 Others
5.2 By Application
5.2.1 Cardiovascular
5.2.2 Urology
5.2.3 Dentistry
5.2.4 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Arthrex Inc
6.1.2 B. Braun Melsungen
6.1.3 Boston Scientific Inc
6.1.4 Becton, Dickinson & Company
6.1.5 Cook Medical
6.1.6 EndoSmart GmbH
6.1.7 Merck KGaA
6.1.8 Terumo IS (Terumo Corporation)
6.1.9 W.L. Gore & Associate Inc.
6.1.10 Zimmer Biomet
7 MARKET OPPORTUNITIES AND FUTURE TRENDS